OJSC “MINSK RESEARCH INSTITUTE OF RADIOMATERIALS”
News
20 may 2015
JSC «Minsk Research Institute of Radio Materials» has been working since 1995 in the field of development and production of medical devices, including those for oxygen therapy.
IK 33 (hereinafter referred to as the inhaler), TU VU 100428401.207–2010, registered by the Ministry of Health of the Republic of Belarus (registration certificate IM-7.96811/1101).
The inhaler is intended for emergency inhalation of an oxygen–air mixture when providing urgent medical care.
The company is the only manufacturer of this product in the Republic of Belarus. At the same time, IK 33 is a worthy example of import-substituting products, which surpass foreign analogues available on the Belarusian market in its technical and operational characteristics.
IK 33 enjoys stable demand among consumers, primarily emergency medical teams, thanks to its reliability and ease of use.
At present, almost every second ambulance team in Belarus is equipped with IK 33.
The oxygen inhaler produced by the company has a number of operational characteristics that distinguish it favorably from similar products:
1. The reduction valve provides smooth regulation of oxygen flow in the range from 5 to 15 l/min, with a maintenance accuracy of ±1 l/min;
2. The original ejector delivers to the patient 3 types of oxygen–air mixtures with oxygen content respectively (50±10), (70±10), and (90±)%vol;
3. The inhaler is equipped with a respiratory protection filter, which is especially relevant when used in emergency situations with increased levels of air contamination by mechanical particles;
4. The transport-operational bag has a rigid frame around the perimeter and an additional valve, allowing the device to be used quickly without unfastening the bag during patient transportation.
The company also provides maintenance services for medical devices and offers free consultations on their use.
Order the oxygen inhaler by phone (017) 398 24 80, MTS (033) 333 95 22, or by e-mail marketing_mm@mail.ru.
The company is ready to consider all possible options for mutually beneficial cooperation.